Content about Paddock Labs

April 21, 2013

Future of pay-for-delay in hands of SCOTUS

Last month, the Supreme Court heard Federal Trade Commission v. Actavis, which could impact the future of the generic drug industry at a time when 80% of all prescriptions dispensed in the United States are generic.

February 7, 2012

Perrigo reports Q2

New product sales and the acquisition of Paddock Labs prompted second-quarter net sales to jump 17% to $838 million for Perrigo for fiscal year 2012, the drug maker said.

July 27, 2011

Perrigo closes acquisition of Paddock Labs

Generic drug maker Perrigo has closed its purchase of Paddock Labs, the company said Tuesday.

June 30, 2011

Perrigo's acquisition of Paddock Labs put on hold

Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.

January 21, 2011

Perrigo to buy Paddock for $540 million

Perrigo will buy Paddock Labs for more than half a billion dollars, Perrigo said Thursday.